To investigate the prognostic role of HB-EGF, we performed Kaplan–Meier survival analysis for determining the relationship between HB-EGF expression and OS in patients with NSCLC, particularly LUAD and LUSC. This evidence concerns the gene HBEGF and non-small cell lung carcinoma.